Aprameya Engineering Ltd
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
- Market Cap ₹ 205 Cr.
- Current Price ₹ 108
- High / Low ₹ 127 / 55.0
- Stock P/E 59.4
- Book Value ₹ 24.4
- Dividend Yield 0.00 %
- ROCE 11.8 %
- ROE 16.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 325 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
12.23 | 25.93 | 35.00 | 78.12 | 65.16 | |
10.64 | 23.52 | 24.95 | 68.67 | 58.81 | |
Operating Profit | 1.59 | 2.41 | 10.05 | 9.45 | 6.35 |
OPM % | 13.00% | 9.29% | 28.71% | 12.10% | 9.75% |
0.09 | 0.08 | 0.04 | 0.21 | 0.46 | |
Interest | 0.90 | 0.87 | 0.14 | 2.08 | 2.11 |
Depreciation | 0.07 | 0.09 | 0.02 | 0.10 | 0.11 |
Profit before tax | 0.71 | 1.53 | 9.93 | 7.48 | 4.59 |
Tax % | 8.45% | 43.79% | 24.87% | 28.21% | 24.84% |
0.65 | 0.86 | 7.46 | 5.37 | 3.46 | |
EPS in Rs | 10.66 | 3.84 | 2.47 | ||
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 36% |
TTM: | -17% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 59% |
TTM: | -36% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 34% |
Last Year: | 16% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 3.74 | 4.34 | 7.00 | 14.00 | 14.00 | 19.04 |
Reserves | -0.00 | -0.00 | 7.45 | 5.92 | 9.37 | 27.39 |
4.03 | 1.48 | 13.69 | 28.74 | 42.05 | 16.33 | |
6.21 | 5.09 | 20.49 | 13.23 | 10.19 | 4.54 | |
Total Liabilities | 13.98 | 10.91 | 48.63 | 61.89 | 75.61 | 67.30 |
0.69 | 0.63 | 1.54 | 1.46 | 1.39 | 1.38 | |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
13.29 | 10.28 | 47.09 | 60.43 | 74.22 | 65.92 | |
Total Assets | 13.98 | 10.91 | 48.63 | 61.89 | 75.61 | 67.30 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
0.06 | 3.58 | 10.41 | -13.49 | -9.98 | |
-0.57 | 0.03 | -0.24 | -1.83 | -1.00 | |
0.54 | -3.67 | -7.69 | 13.04 | 11.11 | |
Net Cash Flow | 0.04 | -0.06 | 2.48 | -2.28 | 0.14 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 182.35 | 57.99 | 278.23 | 195.30 | 325.23 |
Inventory Days | 245.38 | 121.90 | 454.87 | 375.97 | 73.78 |
Days Payable | 268.89 | 146.76 | 1,099.89 | 414.62 | 145.83 |
Cash Conversion Cycle | 158.84 | 33.13 | -366.78 | 156.66 | 253.19 |
Working Capital Days | 159.97 | 49.55 | 203.67 | 194.79 | 319.12 |
ROCE % | 35.32% | 59.31% | 24.90% | 11.75% |
Documents
Announcements
-
Updates
24 April 2025 - Aprameya Engineering reports paid-up capital and reserves; corporate governance norms not applicable.
-
Updates
21 April 2025 - Aprameya Engineering took Rs. 60 lakh unsecured loan from Tata Capital at 15% interest, 18-month tenor.
-
Updates
21 April 2025 - Aprameya Engineering took Rs. 50.1 lakh unsecured loan at 15% interest from Poonawalla Fincorp.
-
Trading Window-XBRL
28 March 2025 - APRAMEYA ENGINEERING LIMITED has informed about Closure of Trading Window
-
Trading Window
28 March 2025 - Closure of trading window from April 1, 2025 as per SEBI regulations.
Annual reports
No data available.
Business Segments[1]
A) Establishing healthcare infrastructure within hospitals and medical care centers.
B) Dealing in high-value medical equipment